Raymond James analyst Brian Peterson lowered the firm’s price target on Doximity (DOCS) to $65 from $83 and keeps an Outperform rating on the shares. Doximity’s Q4 results topped the firm’s model, though with more modest upside than recent quarters and a below consensus outlook for fiscal 2026, the analyst tells investors in a research note. Progress on areas such as the client portal, new products and multi-module buying increase the firm’s confidence in the durable growth rate.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCS:
- Doximity’s Strong Performance and Strategic Positioning Justify Buy Rating Despite Conservative Revenue Guidance
- Doximity price target lowered to $50 from $71 at Canaccord
- Doximity: Strong Performance Amidst Cautious Outlook Warrants Hold Rating
- Doximity’s Strong Q4 Performance Overshadowed by Cautious FY 2026 Outlook: Hold Rating Maintained
- Doximity Hold Rating: Strong Performance Overshadowed by Policy Uncertainties and Cautious Upsell Momentum